Dermatology · USMLE Step 1
Pemphigus vulgaris vs bullous pemphigoid: one split, every difference
Pemphigus vulgaris and bullous pemphigoid compared: desmosomes vs hemidesmosomes, flaccid vs tense blisters, Nikolsky sign, immunofluorescence patterns, triggers and treatment, with USMLE-style questions.
Pemphigus vulgaris and bullous pemphigoid are the two autoimmune blistering diseases every exam asks about. Their names are almost the same, but they attack different structures at different depths of the skin, and almost every difference between them follows from that one fact: where the skin splits.

Pemphigus vulgaris
IgG autoantibodies against desmoglein 3 (and often desmoglein 1) break the desmosomes that hold keratinocytes together, so the cells fall apart (acantholysis) just above the basal layer. The basal cells stay stuck to the basement membrane like a row of tombstones. Patients are usually 40 to 60. Painful mouth erosions often come first, sometimes months before the skin, followed by flaccid blisters that break and leave raw, painful erosions. The Nikolsky sign is positive. Untreated, it is fatal from fluid loss and infection. See the free pemphigus vulgaris flowchart.
Bullous pemphigoid
IgG against the hemidesmosome proteins BP180 (type XVII collagen) and BP230 activates complement and draws in eosinophils, whose enzymes cut the anchors. The whole epidermis lifts, so the blisters are tense and rarely break. It affects people over 70, starts with weeks of itch and urticarial plaques, rarely involves the mouth and heals without scarring. Drugs can trigger it, especially DPP-4 inhibitors (gliptins) and loop diuretics, and it is linked with dementia and Parkinson disease.

Side by side
| Pemphigus vulgaris | Bullous pemphigoid | |
|---|---|---|
| Target | Desmoglein 3 (and 1): desmosomes | BP180 and BP230: hemidesmosomes |
| Split | Intraepidermal (suprabasal) | Subepidermal |
| Blisters | Flaccid, break into erosions | Tense, intact |
| Nikolsky sign | Positive | Negative |
| Mouth | Almost always, often first | Uncommon and mild |
| Age | 40–60 | Over 70 |
| Biopsy | Acantholysis, row of tombstones | Subepidermal blister with eosinophils |
| Immunofluorescence | Intercellular IgG (fishnet) | Linear IgG and C3 at the basement membrane |
| First-line treatment | Rituximab with systemic steroids | Superpotent topical steroid (clobetasol) |
Two more blistering diseases to know
- Dermatitis herpetiformis: intensely itchy grouped vesicles on the elbows, knees and buttocks, linked to celiac disease. Granular IgA in the dermal papillae. Treat with dapsone and a gluten-free diet.
- Pemphigus foliaceus: antibodies to desmoglein 1 only, so the split is high (just under the stratum corneum): crusted scaly erosions on the face and trunk, no mouth involvement.
Practice questions
Question 1DermatologyPemphigus vulgaris
A 52-year-old woman has had painful mouth ulcers for 2 months. She now has flaccid blisters on her trunk that rupture easily, leaving raw erosions. Gentle pressure on normal-looking skin next to a blister makes the epidermis slide off. Antibodies against which structure are responsible?
BP180 is the target in bullous pemphigoid, which gives tense blisters, a negative Nikolsky sign and little mouth involvement.
Mouth erosions first, flaccid blisters and a positive Nikolsky sign are pemphigus vulgaris. IgG against desmoglein 3 (often with desmoglein 1) breaks desmosomes and causes suprabasal acantholysis. Desmoglein 3 dominates in mucosa, which is why the mouth is involved.
Antibodies to epidermal (and tissue) transglutaminase are found in dermatitis herpetiformis, which causes itchy grouped vesicles, not flaccid blisters with mouth erosions.
Type VII collagen is the target in epidermolysis bullosa acquisita, a subepidermal blistering disease with tense blisters at sites of trauma.
Antibodies to desmoglein 1 alone cause pemphigus foliaceus: superficial, crusted erosions with no mouth involvement.
The answer is B.
Key takeaway
Mouth erosions + flaccid blisters + positive Nikolsky = pemphigus vulgaris: anti-desmoglein 3.
Pemphigus vulgaris is caused by IgG against desmoglein 3 (and 1), which breaks the desmosomes between keratinocytes. The split is just above the basal layer, so blisters are thin-roofed and flaccid and the Nikolsky sign is positive. Oral mucosa depends on desmoglein 3, so mouth lesions are early and almost universal.
- Target: desmoglein 3 (± 1)
- Suprabasal acantholysis; row of tombstones
- Fishnet intercellular IgG on direct immunofluorescence
- Treatment: rituximab with corticosteroids
Question 2DermatologyBullous pemphigoid
An 81-year-old man with type 2 diabetes treated with sitagliptin has had months of itching and now has large tense blisters on his thighs and abdomen. His mouth is normal and the Nikolsky sign is negative. A perilesional biopsy is sent for direct immunofluorescence. What will it most likely show?
A fishnet pattern of intercellular IgG is pemphigus, which causes flaccid blisters, mouth erosions and a positive Nikolsky sign.
An itchy older patient on a gliptin with tense blisters, a normal mouth and a negative Nikolsky sign has bullous pemphigoid. IgG against BP180 and BP230 binds along the basement membrane and fixes complement: a linear band of IgG and C3.
Granular IgA in the dermal papillae is dermatitis herpetiformis, with very itchy small grouped vesicles on extensor surfaces and celiac disease.
Linear IgA along the basement membrane is linear IgA bullous dermatosis, often drug-induced (for example vancomycin), with annular 'string of pearls' blisters.
Absent deposits would suggest a non-immune blistering cause such as a bullous drug eruption or friction blisters, not this picture.
The answer is B.
Key takeaway
Tense blisters in an older itchy patient (often on a gliptin) = bullous pemphigoid: linear IgG and C3 at the basement membrane.
Bullous pemphigoid is the most common autoimmune blistering disease, in people over 70. Antibodies against BP180 and BP230 split the skin below the epidermis, so blisters are tense and the Nikolsky sign is negative. DPP-4 inhibitors are a well-known trigger. First-line treatment is a superpotent topical steroid such as clobetasol.
- Target: BP180 (type XVII collagen) and BP230
- Subepidermal blister with eosinophils
- Linear IgG and C3 on direct immunofluorescence
- Stop triggers (gliptins); clobetasol first line
Question 3DermatologyTreatment of pemphigus
A 50-year-old man has confirmed pemphigus vulgaris with extensive skin and mouth erosions. He is started on oral prednisone. Which additional treatment best induces long-term remission and reduces his steroid dose?
Rituximab, an anti-CD20 antibody that removes the B cells making anti-desmoglein antibodies, given with corticosteroids, is first-line treatment for moderate to severe pemphigus. It gives more complete remissions and allows lower steroid doses.
Doxycycline is a steroid-sparing option in bullous pemphigoid, not in pemphigus, which is more severe and needs stronger immunosuppression.
Topical clobetasol is first line in bullous pemphigoid. Extensive pemphigus with mouth disease needs systemic treatment.
Dapsone is the treatment of choice for dermatitis herpetiformis (with a gluten-free diet); it has at most a minor role in pemphigus.
A gluten-free diet treats dermatitis herpetiformis, which is driven by celiac disease. Pemphigus is not related to gluten.
The answer is A.
Key takeaway
Moderate to severe pemphigus: rituximab plus corticosteroids.
Pemphigus vulgaris is life-threatening without treatment. Systemic corticosteroids control it quickly, and rituximab targets the B cells that make the autoantibodies, giving longer remissions and allowing steroids to be tapered. Azathioprine, mycophenolate and IVIG are other options.
- First line: rituximab with systemic steroids
- Steroid-sparing: azathioprine, mycophenolate; IVIG if refractory
- Pemphigoid instead: topical clobetasol, doxycycline
- Dermatitis herpetiformis instead: dapsone and a gluten-free diet
Go deeper in the Knowledge Hub: autoimmune blistering diseases, bullous pemphigoid and blistering skin diseases. The free pemphigus vulgaris flowchart shows the disease from cause to treatment.